In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.

The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.

In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.

The governmental funding will support the company's plans for a 1,350-participant trial that aims to further validate its protein-based cancer early detection assay. The round, which was led by ...

The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

According to the government, Tina Ball and her lab company knowingly billed North Carolina Medicaid for urine drug tests that were medically unnecessary.

The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.

Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.

NEW YORK – While most of the attention has been on Vice President Kamala Harris and former President Donald Trump in the presidential election, several down-ballot races could also impact a number of ...